Table 4. Interaction of current cigarette smoking and NAT2 acetylator phenotype on diminished ovarian reserve (DOR).
All womena | Women without PCOSb | |||||||
---|---|---|---|---|---|---|---|---|
Rapid/Intermediate | Slow | Rapid/Intermediate | Slow | |||||
N | OR (95% CI) | N | OR (95% CI) | N | OR (95% CI) | N | OR (95% CI) | |
Nonsmoker | 38 | 1.00 | 25 | 0.42(0.05–3.44) | 26 | 1.00 | 16 | 0.35(0.02–5.14) |
Passive smoker | 39 | 1.16(0.30–4.50) | 24 | 2.42(0.37–15.97) | 25 | 1.43(0.31–6.66) | 9 | 1.92(0.11–33.78) |
Active smoker | 18 | 1.25(0.16–9.54) | 11 | 1.59(0.26–9.70) | 13 | 1.71(0.17–17.12) | 3 | 2.50(0.15–42.6) |
a Adjusted for age, race, and polycystic ovary syndrome; p-value for interaction = 0.67
b Adjusted for age and race; p-value for interaction = 0.69